{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:47:05Z","timestamp":1781758025156,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":2440,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1074\/jbc.m113.501635","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T07:06:17Z","timestamp":1387436777000},"page":"3666-3676","source":"Crossref","is-referenced-by-count":20,"title":["scyllo-Inositol Promotes Robust Mutant Huntingtin Protein Degradation"],"prefix":"10.1016","volume":"289","author":[{"given":"Aaron Y.","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia P.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnne","family":"McLaurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.501635_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1074\/jbc.M113.501635_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","article-title":"Huntington disease models and human neuropathology: similarities and differences","volume":"115","author":"Vonsattel","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1074\/jbc.M113.501635_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington's disease","volume":"238","author":"Arrasate","year":"2012","journal-title":"Exp. Neurol"},{"key":"10.1074\/jbc.M113.501635_bib4","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/j.1742-4658.2008.06562.x","article-title":"Huntington's disease: degradation of mutant huntingtin by autophagy","volume":"275","author":"Sarkar","year":"2008","journal-title":"FEBS J"},{"key":"10.1074\/jbc.M113.501635_bib5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington's disease","volume":"448","author":"Bennett","year":"2007","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.501635_bib6","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","article-title":"Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis","volume":"30","author":"Miller","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M113.501635_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nchembio.694","article-title":"Identifying polyglutamine protein species in situ that best predict neurodegeneration","volume":"7","author":"Miller","year":"2011","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.M113.501635_bib8","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M113.501635_bib9","doi-asserted-by":"crossref","first-page":"e29199","DOI":"10.1371\/journal.pone.0029199","article-title":"Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments","volume":"6","author":"Butler","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M113.501635_bib10","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.2628045100","article-title":"A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila","volume":"100","author":"Apostol","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.501635_bib11","doi-asserted-by":"crossref","first-page":"16685","DOI":"10.1073\/pnas.0707842104","article-title":"A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2\u20138 in the R6\/2 transgenic mouse","volume":"104","author":"Chopra","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.501635_bib12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/hmg\/ddr500","article-title":"An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors","volume":"21","author":"Fuentealba","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.M113.501635_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2010.03.023","article-title":"Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish","volume":"39","author":"van Bebber","year":"2010","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.M113.501635_bib14","first-page":"127","article-title":"Detection of mutant huntingtin aggregation conformers and modulation of SDS-soluble fibrillar oligomers by small molecules","volume":"1","author":"Sontag","year":"2012","journal-title":"J. Huntingtons Dis"},{"key":"10.1074\/jbc.M113.501635_bib15","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.1222663110","article-title":"Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes","volume":"110","author":"Sontag","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.501635_bib16","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1074\/jbc.M112.421685","article-title":"The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides","volume":"288","author":"Gillis","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.501635_bib17","doi-asserted-by":"crossref","first-page":"19958","DOI":"10.1074\/jbc.M113.477984","article-title":"Prefoldin protects neuronal cells from polyglutamine toxicity by preventing aggregation formation","volume":"288","author":"Tashiro","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.501635_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nn.3367","article-title":"Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance","volume":"16","author":"Lu","year":"2013","journal-title":"Nat. Neurosci"},{"key":"10.1074\/jbc.M113.501635_bib19","doi-asserted-by":"crossref","first-page":"18495","DOI":"10.1074\/jbc.M906994199","article-title":"Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid \u03b2 peptide and inhibit A\u03b2-induced toxicity","volume":"275","author":"McLaurin","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.501635_bib20","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.bbadis.2012.07.003","article-title":"Inhibition of amyloid-\u03b2 peptide aggregation rescues the autophagic deficits in the TgCRND8 mouse model of Alzheimer disease","volume":"1822","author":"Lai","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.501635_bib21","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1471-4159.2009.06054.x","article-title":"Inducible overexpression of wild type \u03b1-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death","volume":"109","author":"Vekrellis","year":"2009","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.501635_bib22","doi-asserted-by":"crossref","first-page":"e24032","DOI":"10.1371\/journal.pone.0024032","article-title":"Sodium\/myo-inositol transporters: substrate transport requirements and regional brain expression in the TgCRND8 mouse model of amyloid pathology","volume":"6","author":"Fenili","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M113.501635_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","article-title":"Soluble A\u03b2 oligomer production and toxicity","volume":"120","author":"Larson","year":"2012","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.501635_bib24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.501635_bib25","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1038\/cddis.2011.81","article-title":"The Parkinson's disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activity","volume":"2","author":"Lichtenberg","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1074\/jbc.M113.501635_bib26","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1182\/blood-2011-12-397729","article-title":"Integrated protein quality-control pathways regulate free \u03b1-globin in murine \u03b2-thalassemia","volume":"119","author":"Khandros","year":"2012","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.501635_bib27","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1073\/pnas.96.13.7388","article-title":"Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei","volume":"96","author":"Karpuj","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.501635_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0202-143","article-title":"Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine","volume":"8","author":"Karpuj","year":"2002","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M113.501635_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M113.501635_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1326-6-37","article-title":"Reduction of mutant huntingtin accumulation and toxicity by lysosomal cathepsins D and B in neurons","volume":"6","author":"Liang","year":"2011","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.M113.501635_bib31","doi-asserted-by":"crossref","first-page":"17471","DOI":"10.1074\/jbc.M112.352781","article-title":"Cathepsins L and Z are critical in degrading polyglutamine-containing proteins within lysosomes","volume":"287","author":"Bhutani","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.501635_bib32","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","article-title":"Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations","volume":"141","author":"Lee","year":"2010","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.501635_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/dmd.112.050054","article-title":"Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)","volume":"41","author":"Kazmi","year":"2013","journal-title":"Drug Metab. Dispos"},{"key":"10.1074\/jbc.M113.501635_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-4159.2011.07314.x","article-title":"Autophagy deregulation in neurodegenerative diseases-recent advances and future perspectives","volume":"118","author":"Cheung","year":"2011","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.501635_bib35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4161\/auto.6845","article-title":"Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"key":"10.1074\/jbc.M113.501635_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0968-0004(90)90019-8","article-title":"Peptide sequences that target cytosolic proteins for lysosomal proteolysis","volume":"15","author":"Dice","year":"1990","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/jbc.M113.501635_bib37","doi-asserted-by":"crossref","first-page":"e46834","DOI":"10.1371\/journal.pone.0046834","article-title":"The role of chaperone-mediated autophagy in huntingtin degradation","volume":"7","author":"Qi","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M113.501635_bib38","doi-asserted-by":"crossref","first-page":"62079","DOI":"10.1155\/JBB\/2006\/62079","article-title":"Signaling, polyubiquitination, trafficking, and inclusions: sequestosome 1\/p62's role in neurodegenerative disease","volume":"2006","author":"Wooten","year":"2006","journal-title":"J. Biomed. Biotechnol"},{"key":"10.1074\/jbc.M113.501635_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/fnl.09.69","article-title":"Role of the ubiquitin-proteasome system and autophagy in polyglutamine neurodegenerative diseases","volume":"5","author":"Jana","year":"2010","journal-title":"Future Neurol"},{"key":"10.1074\/jbc.M113.501635_bib40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","article-title":"Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice","volume":"180","author":"Wang","year":"2008","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M113.501635_bib41","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.1523\/JNEUROSCI.4393-08.2008","article-title":"Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons","volume":"28","author":"Tydlacka","year":"2008","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M113.501635_bib42","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jnr.21287","article-title":"Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease","volume":"85","author":"Hunter","year":"2007","journal-title":"J. Neurosci. Res"},{"key":"10.1074\/jbc.M113.501635_bib43","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.cell.2008.07.039","article-title":"Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies","volume":"134","author":"Newton","year":"2008","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.501635_bib44","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1021\/jp311350r","article-title":"Binding mechanism of inositol stereoisomers to monomers and aggregates of A\u03b2(16\u201322)","volume":"117","author":"Li","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"10.1074\/jbc.M113.501635_bib45","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/jp208567n","article-title":"Binding of inositol stereoisomers to model amyloidogenic peptides","volume":"116","author":"Li","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1074\/jbc.M113.501635_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1573407211309010006","article-title":"Structural features of small molecule amyloid-\u03b2 self-assembly inhibitors","volume":"9","author":"T\u00f6r\u00f6k","year":"2013","journal-title":"Curr. Bioact. Compd"},{"key":"10.1074\/jbc.M113.501635_bib47","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (\u2212)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.M113.501635_bib48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","article-title":"Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release","volume":"10","author":"Jana","year":"2001","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.M113.501635_bib49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molcel.2004.12.021","article-title":"Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation","volume":"17","author":"Bennett","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.M113.501635_bib50","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1074\/jbc.M806269200","article-title":"Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease","volume":"284","author":"Mitra","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.501635_bib51","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1523\/JNEUROSCI.5673-09.2010","article-title":"Acute polyglutamine expression in inducible mouse model unravels ubiquitin\/proteasome system impairment and permanent recovery attributable to aggregate formation","volume":"30","author":"Ortega","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M113.501635_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.501635_bib53","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1074\/jbc.M113.501635_bib54","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.21051","article-title":"Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-\u03b2 oligomers","volume":"60","author":"Townsend","year":"2006","journal-title":"Ann. Neurol"},{"key":"10.1074\/jbc.M113.501635_bib55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm1423","article-title":"Cyclohexanehexol inhibitors of A\u03b2 aggregation prevent and reverse Alzheimer phenotype in a mouse model","volume":"12","author":"McLaurin","year":"2006","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M113.501635_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00109-007-0156-7","article-title":"Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology","volume":"85","author":"Fenili","year":"2007","journal-title":"J. Mol. Med"},{"key":"10.1074\/jbc.M113.501635_bib57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.expneurol.2013.10.001","article-title":"Combination therapy in a transgenic model of Alzheimer's disease","volume":"250","author":"Aytan","year":"2013","journal-title":"Exp. Neurol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925819747541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925819747541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.501635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T20:40:21Z","timestamp":1641242421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925819747541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0021925819747541"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.501635","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}